Manufacture of pharmaceutical preparations
PALLA PHARMA NORWAY AS
Revenue 2024
NOK 213.2m
Operating profit
NOK 19.7m
Equity
NOK 52.6m
Incorporated
2016
Employees
72
Share capital
NOK 3.6m
Key figures · 2024
Current ratio
1.08
Equity ratio
31.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 9.2% | |
| Net margin (%%) | 6.3% | |
| Return on assets (%%) | 11.7% | |
| Likviditet | ||
| Current ratio | 1.08 | |
| Working capital | 7.4m | |
| Soliditet | ||
| Equity ratio (%%) | 31.3% | |
| Debt-to-equity ratio | 2.20 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.